SNP Genotyping and Analysis Market, By Technology, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Genotyping refers to determining differences in the genetic make-up by analyzing DNA sequences of individuals. Genotyping has wide variety of applications ranging from drug discovery to disease diagnosis. Genetic diseases (which have different genetic make ups in certain places in DNA) can be identified and diagnosed by comparing those sequences with the reference sequences.

Restraints of the Global SNP Genotyping and Analysis Market

Major factors hampering the growth of the SNP genotyping and analysis market during the forecast period constitutes of imperfect protocols leading to large redundant data, and high costs of devices.

Key features of the study:

• This report provides in-depth analysis of the global SNP genotyping and analysis market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global SNP genotyping and analysis market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include LGC Limited, Fluidigm Corporation, Illumina, Inc., Life Technologies Corporation, PREMIER Biosoft, Thermo Fisher Scientific, and Sequenom, Inc.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global SNP genotyping and analysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

• Global SNP Genotyping and Analysis Market, By Technology:
  • SNP Microarray
  • Taqman Allelic Discrimination
  • SNP Pyrosequencing Technologies
  • ABISNPlex
  • Sequenom Mass-Array MALDI-TOF
  • Others
• Global SNP Genotyping and Analysis Market, By Application:
  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Breeding and Animal Livestock
• Global SNP Genotyping and Analysis Market, By Geography:
  • North America
• By Technology
  • SNP Microarray
  • Taqman Allelic Discrimination
  • SNP Pyrosequencing Technologies
  • ABISNPlex
  • Sequenom Mass-Array MALDI-TOF
  • Others
• By Application
  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Breeding and Animal Livestock
• By Country:
  • U.S.
  • Canada
  • Europe
• By Technology
  • SNP Microarray
  • Taqman Allelic Discrimination
  • SNP Pyrosequencing Technologies
  • ABISNPlex
  • Sequenom Mass-Array MALDI-TOF
  • Others
• By Application
  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Breeding and Animal Livestock
• By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
• By Technology
  • SNP Microarray
  • Taqman Allelic Discrimination
  • SNP Pyrosequencing Technologies
  • ABISNPlex
  • Sequenom Mass-Array MALDI-TOF
  • Others
• By Application
  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Breeding and Animal Livestock
• By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
• By Technology
  • SNP Microarray
  • Taqman Allelic Discrimination
  • SNP Pyrosequencing Technologies
  • ABISNPlex
  • Sequenom Mass-Array MALDI-TOF
  • Others
• By Application
  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Breeding and Animal Livestock
• By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East:
• By Technology
  • SNP Microarray
  • Taqman Allelic Discrimination
  • SNP Pyrosequencing Technologies
  • ABISNPlex
  • Sequenom Mass-Array MALDI-TOF
  • Others
• By Application
  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Breeding and Animal Livestock
• By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
• By Technology
  • SNP Microarray
  • Taqman Allelic Discrimination
  • SNP Pyrosequencing Technologies
  • ABISNPlex
  • Sequenom Mass-Array MALDI-TOF
  • Others
• By Application
  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Breeding and Animal Livestock
• By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
• Company Profiles
  • LGC Limited *
• Company Overview
• Product Portfolio
• Financial Performance
• Key Strategies
• Recent Developments
  • Fluidigm Corporation
  • Illumina, Inc.
  • Life Technologies Corporation
  • PREMIER Biosoft
  • Thermo Fisher Scientific
  • Sequenom, Inc.

"*" marked represents similar segmentation in other categories in the respective section.